Table 2.
Patient Characteristics and tumor response
| Characteristics | Total patients n=132 |
|---|---|
| Gender | |
| Female | 54 (41%) |
| Male | 78 (59%) |
| Age, years (mean, range) | 57 (25–87) |
| Pre-operative clinical stage | |
| Stage II | 30 (23%) |
| Stage III | 102 (77%) |
| Neoadjuvant treatment | |
| 5-FU/RT | 52 (39%) |
| 5-FU/RT and mFOLFOX-6 | 80 (61%) |
| Tumor response | |
| pCR | 33 (25%) |
| Non-pCR | 99 (75%) |
5-FU: 5-flourouracil; RT: radiation; mFOLFOX-6: Modified FOLFOX-6; pCR: Pathologic complete response.